Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.

The FDA said its move Thursday was based on studies showing that the Zyn pouches contain “substantially ... dividend yield of 4.51% at current stock prices. The yield on the consumer staples ...

The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...

Federal health officials have authorized the marketing and sale of Zyn nicotine pouches, marking the first time the Food and Drug Administration authorized these popular products that go between a ...

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.

Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...

Zyn nicotine pouches hit the market as a run-of-the-mill tobacco-replacement product, but over the past few years, they’ve gone viral thanks to so-called “Zynfluencers”: content creators who post ...

(The Hill) — Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine pouches can help adult smokers cut back or switch completely.

The FDA said its move Thursday was based on studies showing that the Zyn pouches contain "substantially ... dividend yield of 4.51% at current stock prices. The yield on the consumer staples ...

Use extra caution. && FILE - Containers of Zyn, a smokeless nicotine pouch, are displayed for sale among other nicotine and tobacco products at a newsstand on Feb. 23, 2024, in New York.